Cognyxx Pharmaceuticals

Treatment for Cardiovascular and Neurodegenerative Disorders

Health Tech & Life Sciences
Active
Pre-Funding - Founded 2018
Website ↗
Total raised
Stage
Pre-Funding
Founded
2018
Headcount
6
HQ
-
Sector
Health Tech & Life Sciences

About

Cognyxx Pharmaceuticals is developing a solution to empower the immune system in treatments for cardiovascular and neurodegenerative disorders.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

degenerative-diseasesneurosciencecardiology